Methods for treating hypercholesterolemia and reducing LDL-C using antibodies to PCSK9
US9724411B2 · kind B2 · utility
11Cited by
34References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 9, 2013 |
| Grant date | Aug 8, 2017 |
| Priority date | — |
| Expiry date | Jan 9, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods for treating hypercholesterolemia and reducing LDL-C. The methods of the present invention comprise administering to a subject in need thereof a therapeutic composition comprising an anti-PCSK9 antibody or antigen-binding fragment thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.